Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Assets (2016 - 2025)

Veracyte (VCYT) has disclosed Current Assets for 14 consecutive years, with $488.4 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 31.19% to $488.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $488.4 million through Dec 2025, up 31.19% year-over-year, with the annual reading at $488.4 million for FY2025, 31.19% up from the prior year.
  • Current Assets hit $488.4 million in Q4 2025 for Veracyte, up from $449.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $488.4 million in Q4 2025 to a low of $229.3 million in Q3 2021.
  • Historically, Current Assets has averaged $315.5 million across 5 years, with a median of $288.0 million in 2023.
  • Biggest YoY gain for Current Assets was 115.04% in 2021; the steepest drop was 38.08% in 2021.
  • Year by year, Current Assets stood at $243.1 million in 2021, then grew by 2.28% to $248.6 million in 2022, then rose by 14.88% to $285.6 million in 2023, then skyrocketed by 30.34% to $372.3 million in 2024, then soared by 31.19% to $488.4 million in 2025.
  • Business Quant data shows Current Assets for VCYT at $488.4 million in Q4 2025, $449.2 million in Q3 2025, and $414.7 million in Q2 2025.